Trisomy 8 alters chromatin conformations and activates Y chromosome…
Understanding how trisomy 8 rewires blood cells toward leukemia opens pathways to detect and potentially prevent progression in myelodysplastic syndrome patients.
- Lab
- Preclinical
- Early trials
- Late trials
- In practice
Recent advances in CAR T and CAR NK cell therapy for AML
New CAR-NK cell approaches targeting specific immune mismatches offer researchers a fresh strategy against leukemia relapse after transplant.
Standard additionMechanistic overview and suggested strategies to overcome BCL-2…
Mapping exactly how TP53-mutated leukemias resist treatment reveals specific vulnerabilities researchers can now design combination therapies to target.
Standard additionMutational landscape changes of AML in patients relapsing after…
Early detection of leukemia relapse after transplant—rather than mutation type—best predicts outcomes, guiding when closer monitoring matters most.
Standard additionAdvancing acute myeloid leukemia immunotherapy
Gene signatures now help doctors select the most effective natural killer cells for each patient, while better preservation keeps cells potent longer.